Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL16636385 | 0.89 | LMNA (0.52) | LMNATHRB | |
| Methyl Alcohol SCHEMBL5434659 | 0.82 | LMNA (0.86) | LMNATHRB | |
| SCHEMBL9459 | 0.82 | — | — | |
| SCHEMBL2094168 | 0.82 | LMNA (1.00) | LMNATHRB | |
| Acetone SCHEMBL590699 | 0.80 | LMNA (0.71) | LMNATHRB | |
| Bicarbonate SCHEMBL28942687 | 0.80 | LMNA (0.71) | LMNATHRB | |
| Bicarbonate SCHEMBL28895866 | 0.80 | LMNA (0.71) | LMNATHRB | |
| Bicarbonate SCHEMBL5374586 | 0.80 | LMNA (0.71) | LMNATHRB | |
| Isopropyl Alcohol SCHEMBL5499438 | 0.79 | LMNA (0.80) | LMNATHRB | |
| Hydroxyamine SCHEMBL7122122 | 0.79 | LMNA (0.80) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110143856-B | Method for synthesizing dichocrocis punctiferalis sex pheromone (Z, E) -10-hexadecene aldehyde compound | 山东省农药科学研究院 | 2022-09-02 | — | — | CN | claimed |
| EP-0298555-B1 | PROCESS FOR SYNTHESIS OF AMINOMETHYLENE PHOSPHONOALKYLPHOSPHINATES | Norwich Eaton Pharmaceuticals, Inc. (US) | 1991-09-18 | — | — | EP | claimed |
| US-4963681-A | Process for synthesis of aminomethylene phosphonoalkylphosphinates | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1990-10-16 | — | — | US | claimed |
| EP-0298555-A1 | Process for synthesis of aminomethylene phosphonoalkylphosphinates | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-01-11 | — | — | EP | claimed |
| JP-1085985-A | — | — | None | — | — | JP | disclosed |
| CN-110143856-B | Method for synthesizing dichocrocis punctiferalis sex pheromone (Z, E) -10-hexadecene aldehyde compound | 山东省农药科学研究院 | 2022-09-02 | — | — | CN | disclosed |
| US-9155804-B2 | Contrast enhancement agents and method of use thereof | GENERAL ELECTRIC COMPANY (US) | 2015-10-13 | — | — | US | disclosed |
| EP-2900276-A1 | BIFUNCTIONAL CHELATING AGENTS | General Electric Company (US) | 2015-08-05 | — | — | EP | disclosed |
| US-20140086846-A1 | CONTRAST ENHANCEMENT AGENTS AND METHOD OF USE THEREOF | GENERAL ELECTRIC COMPANY (US) | 2014-03-27 | — | — | US | disclosed |
| US-20140088314-A1 | BIFUNCTIONAL CHELATING AGENTS | GENERAL ELECTRIC COMPANY (US) | 2014-03-27 | — | — | US | disclosed |
| EP-0298555-B1 | PROCESS FOR SYNTHESIS OF AMINOMETHYLENE PHOSPHONOALKYLPHOSPHINATES | Norwich Eaton Pharmaceuticals, Inc. (US) | 1991-09-18 | — | — | EP | disclosed |
| US-4963681-A | Process for synthesis of aminomethylene phosphonoalkylphosphinates | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1990-10-16 | — | — | US | disclosed |
| EP-0298555-A1 | Process for synthesis of aminomethylene phosphonoalkylphosphinates | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086846-A1 | CONTRAST ENHANCEMENT AGENTS AND METHOD OF USE THEREOF | MLX, HAX1, BMX | LMNA 1375/4885THRB 2247/4885 |
| US-20140088314-A1 | BIFUNCTIONAL CHELATING AGENTS | C3AR1, C1R, C9 | LMNA 3428/4885THRB 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.